Bacteria Bacterium FDA Approval RNA 
XTalks
AUGUST 2, 2023
Paxlovid was first authorized under the FDA Emergency Use Authorization in December 2021 ; however, it has received FDA approval on May 25, 2023. pneumoniae serotypes) replaced the company’s first pneumococcal conjugate vaccine Prevnar (PCV7, approved by the FDA in February 2000) in a February 2010 FDA approval.
XTalks
DECEMBER 24, 2020
Several saliva-based tests also received FDA approvals and authorizations, making sample collection easier and less invasive compared with traditional nasopharyngeal swabbing. Charpentier demonstrated that the CRISPR/Cas system functions to provide adaptive immunity against foreign DNA in prokaryotes such as bacteria and archaea.
Expert insights. Personalized for you.
98 
Let's personalize your content